Ticker Details
Abbott Laboratories Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
IPO Date:	December 24, 1981
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$158.63B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.68 | 0.97%
Avg Daily Range (30 D):	$1.17 | 1.33%
Avg Daily Range (90 D):	$1.21 | 1.21%

Institutional Daily Volume
Avg Daily Volume:	5.67M
Avg Daily Volume (30 D):	9.98M
Avg Daily Volume (90 D):	8.96M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	75

Institutional Trades
Total Institutional Trades:	102,768
Avg Institutional Trade:	$5.78M
Avg Institutional Trade (30 D):	$8.8M
Avg Institutional Trade (90 D):	$12.99M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	17

Market Closing Trades
Avg Closing Trade:	$54.89M
Avg Closing Trade (30 D):	$176.06M
Avg Closing Trade (90 D):	$193.98M
Avg Closing Volume:	662.84K

News

Jun 8, 2026 @ 9:25 AM Why Grail Could Be the Sleeper Stock Everyone's Ab... Source: Keith Speights

Jun 5, 2026 @ 5:57 PM A Grandma Bought PediaSure To Help Her Grandson Gr... Source: Vandana Singh

Jun 5, 2026 @ 2:30 PM Chemiluminescence Immunoassay Market Expected to R... Source: Marketsandmarkets

Jun 4, 2026 @ 5:53 PM [Latest] Non-Invasive Blood Glucose Monitoring Dev... Source: Zion Market Research

Jun 3, 2026 @ 4:05 PM 1 Sector Warren Buffett and Greg Abel Are Largely ... Source: Adria Cimino

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$3.59	$.62
Diluted EPS	$3.57	$.61
Revenue	$45.13B	$11.16B
Gross Profit	$25.39B	$6.27B
Net Income / Loss	$6.28B	$1.08B
Operating Income / Loss	$7.71B	$1.35B
Cost of Revenue	$19.74B	$4.89B
Net Cash Flow	$247M	$-1696M
PE Ratio